Willow Investor Deck

Investment Highlights • Produces consistent, pharmaceutical-grade cannabinoid compounds • Ability to reliably supply strong growth markets – Wide range of pharmaceutical applications, extensive consumer product market expected • Proven team with scientific and business expertise to successfully commercialize production • Partnered with Noramco, a leading global provider of active pharmaceutical ingredients, to drive post-commercialization success • Clear path to commercialization – Scale up with Noramco to commence H1 2020 • Strong financial position with ample liquidity to fund commercial production 2 Positioned to be leading high-quality ingredients manufacturer serving pharmaceutical and CPG markets Market expected to grow 10x over the next 10 years to $100B